These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9066008)
1. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage. Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008 [TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
3. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor. Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580 [TBL] [Abstract][Full Text] [Related]
4. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T; Behrendt N; Ploug M Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. Elia C; Cassol E; Sidenius N; Blasi F; Castagna A; Poli G; Alfano M J Leukoc Biol; 2007 Nov; 82(5):1212-20. PubMed ID: 17704294 [TBL] [Abstract][Full Text] [Related]
6. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041 [TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Jardí M; Inglés-Esteve J; Burgal M; Azqueta C; Velasco F; López-Pedrera C; Miles LA; Félez J Thromb Haemost; 1996 Dec; 76(6):1009-19. PubMed ID: 8972026 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system. Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451 [TBL] [Abstract][Full Text] [Related]
10. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT). Reinartz J; Link J; Todd RF; Kramer MD Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643 [TBL] [Abstract][Full Text] [Related]
11. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. Nip J; Rabbani SA; Shibata HR; Brodt P J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755 [TBL] [Abstract][Full Text] [Related]
12. Regulated localization confers multiple functions on the protease urokinase plasminogen activator. Wells JM; Strickland S J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470 [TBL] [Abstract][Full Text] [Related]
13. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells. Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554 [TBL] [Abstract][Full Text] [Related]
14. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711 [TBL] [Abstract][Full Text] [Related]
15. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158 [TBL] [Abstract][Full Text] [Related]
16. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor. Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity. Stillfried GE; Saunders DN; Ranson M Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442 [TBL] [Abstract][Full Text] [Related]
18. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401 [TBL] [Abstract][Full Text] [Related]
19. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
20. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Reuning U; Magdolen V; Hapke S; Schmitt M Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]